PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company.
PSI CRO explores solid site relationships and how they are the backbone of successful clinical trials. Without happy, supported sites, enrolment simply cannot happen predictably or within budgetary constraints.
British pharmaceutical companies are set to gain up to £250 million over the next five years as part of a Vietnamese law change that makes it easier to sell UK-made medicines to the country.
In the face of volatile energy pricing and grid instability, Aggreko is highlighting the potential for battery energy storage systems (BESS) and battery hybrids to help increase resilience and on-site efficiency.
PSI, a global Contract Research Organisation, explains why selecting a global safety database is one of the most critical decisions in managing clinical trial data.
Aptar CSP Technologies, part of AptarGroup, has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen.
